These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Killing of Escherichia coli by beta-lactams at different inocula.
    Author: Tam VH, Ledesma KR, Chang KT, Wang TY, Quinn JP.
    Journal: Diagn Microbiol Infect Dis; 2009 Jun; 64(2):166-71. PubMed ID: 19304437.
    Abstract:
    Escherichia coli is a common pathogen implicated in intra-abdominal infections; a heavy bacterial burden is often encountered, and the clinical utility of beta-lactams may be limited by the inoculum effect. We examined the impact of a high inoculum on the bactericidal activity of various beta-lactams against E. coli. Two wild-type, an extended-spectrum beta-lactamase-producing, and a plasmid-mediated AmpC-producing strains, were used. Clinically achievable concentrations of piperacillin/tazobactam, ceftriaxone, and ertapenem were investigated. Viable bacterial burden was serially determined for 24 h by quantitative culture. All 3 beta-lactams demonstrated significant killing against the standard inoculum (10(5) CFU/mL) of susceptible strains. However, the activity of piperacillin/tazobactam was drastically reduced with 10(8) CFU/mL of bacteria. Ertapenem was the least affected by the inoculum effect in all strains. Our results suggest that different beta-lactam subclasses have a distinct killing profile against a dense E. coli population. Comparative in vivo/clinical investigations are warranted to validate our findings.
    [Abstract] [Full Text] [Related] [New Search]